Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2559 of 6351
-
Could a depression drug fight prostate cancer?
Disease control CompletedThis phase II trial studies phenelzine sulfate in treating patients with prostate cancer that has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of antidepressant that works by decreasing the amount of a protein called monoamine oxidase (MAO…
Phase 2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
10-Year hip implant study shows how well it lasts
Disease control CompletedClinical and radiological 10 year results of Excia T® Hip Stem
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Brain zapping study aims to sharpen memory and focus across multiple disorders
Knowledge-focused Recruiting nowIn the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:49 UTC
-
Sound waves vs. Parkinson's: tiny trial tests brain zapping
Disease control CompletedThis is primarily a safety protocol to evaluate the safety of subthalamotomy using Transcranial ExAblate for treatment of Parkinson's Disease (PD) motor features.
Sponsor: InSightec • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Exercise may boost memory in kids treated for brain cancer
Symptom relief CompletedBackground: \- More children with cancer are surviving into adulthood. Some side effects from treatment go away quickly. But some problems may not go away or may only show up months or years later. These problems are called late effects. Late effects can cause difficulties in co…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Home health visitors show promise for moms and kids in rural south africa
Disease control CompletedThe purpose of this early Phase 2 comparison trial is to evaluate the impact of community health worker (CHW) home visitors on pregnant women and their children in a rural setting in the rural Eastern Cape of South Africa. The intervention provided by the CHWs targets underweight…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Blood test may predict need for hip revision surgery
Diagnosis Stopped earlyThe purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revi…
Sponsor: OrthoCarolina Research Institute, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Battle of the bacteria: which h. pylori treatment wins?
Disease control Recruiting nowTo compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo pill could help diabetics on insulin
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in combination with Insulin in patients with type 2 Diabetes for 16 weeks administration.
Phase 4 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New 9-Day combo shows promise for rare bone marrow disease
Disease control CompletedSevere acquired aplastic anaemia (SAA) is a bone marrow failure disease characterized by pancytopenia and a hypocellular bone marrow. The corn pathophysiological mechanism is the destruction of hematopoietic stem/progenitor cells mediated by auto-reactive effector T cells. Immuno…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can patients recall events during ER sedation? a study asks.
Knowledge-focused CompletedThe purpose of this study is to determine the incidence of recall in patients managed in emergency department with a procedural sedation protocol using propofol in a population of 250 .
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Gene map of tumors could personalize cancer therapy
Knowledge-focused Recruiting nowThis research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer). Genomic profiling studies the deoxyribonucleic acid (DNA) of a tumor to detect genetic changes …
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo aims to fight Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-56021927 and prednisone, determine safety of the combination and evaluate in a descriptive manner the efficacy in these participants. It …
Phase 1 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Gut bacteria cocktail shows promise for autism GI troubles
Disease control CompletedThis is an open-label clinical trial to investigate a combination therapy for treating gastrointestinal problems in children with autism spectrum disorders. The combination therapy includes beneficial bacteria.
Phase 1/2 • Sponsor: Arizona State University • Aim: Disease control
Last updated Jun 26, 2026 16:52 UTC
-
Glow-in-the-dark dye could help surgeons remove brain tumors completely
Knowledge-focused OngoingRemoving a tumor from a patients brain is hard to do because, very often, brain tumors do not have boundaries that are easy for the patients surgeon to find. In many cases, the surgeon can't tell exactly where the tumor begins or ends. The surgeon usually can remove most of the p…
Phase 1 • Sponsor: David W. Roberts • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Blood RNA may reveal hidden liver cancers
Diagnosis Stopped earlyThe study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Yoga may ease nicotine withdrawal and stress during quit attempts
Symptom relief CompletedThe primary aim of this research study is to examine the effects of an 8-week yoga program on aspects related to nicotine dependence, stress, and coping during a smoking quit attempt. Guided by initial studies reporting on the effects of yoga on putative mediators of smoking rel…
Sponsor: Jasper A. Smits • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks sorafenib safety in Hard-to-Treat thyroid cancer
Disease control OngoingThis is a non-interventional, multi center post-authorization safety study that includes all patients diagnosed as Unresectable Differentiated Thyroid Carcinoma (DTC) and treated with Sorafenib within a certain period. The investigator should have made the choice of treatment (NE…
Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug shows promise for calming Tourette's tics in kids
Symptom relief CompletedTourette's Syndrome is a neurological disease characterized by motor and vocal tics. It has been hypothesized that abnormal interactions of dopamine with its receptors may cause the tics. The purpose of this study is to test the hypothesis that a drug (ecopipam) that selectively …
Phase 2 • Sponsor: Emalex Biosciences Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New skin patch could make grafts more flexible and less scarred
Disease control CompletedIn reconstructive surgery , most losses of cutaneous substance require the use of a thin skin graft . This technique allows epidermization of the defect by applying a thin layer of autologous epidermis. It does not reconstitute the injured skin. Transplants cause retractile scars…
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC